<PAGE>
FORM 10-Q/A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND
EXCHANGE ACT OF 1934
For the quarterly period ended February 28, 1995
------------------------------------------------
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND
EXCHANGE ACT OF 1934
For the transition period from ______________________ to ______________________
Commission file number 0-13879
---------------------------------------------------------
Salick Health Care, Inc.
- -------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 95-4333272
- ------------------------------- --------------------------
(State or other jurisdiction of (I.R.S Employer
incorporation or organization) identification number)
8201 Beverly Boulevard, Los Angeles, California 90048-4520
- -------------------------------------------------------------------------------
(Address of principal executive offices)
(Zip code)
(213) 966-3400
- -------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
No Change
- -------------------------------------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No
----- -----
Indicate the number of shares outstanding of each of the issuer's classes of
common stock as of the latest practicable date: _______
10,366,297 shares of common stock
- -------------------------------------------------------------------------------
par value, at March 31, 1995
- -------------------------------------------------------------------------------
Page 1 of 4 Pages
Exhibit Index on Page 3
<PAGE>
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant had duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.
SALICK HEALTH CARE, INC.
------------------------------------
(Registrant)
/s/ BERNARD SALICK, M.D.
------------------------------------
Date: April 18, 1995 Bernard Salick, M.D.
Chairman and Chief Executive Officer
(Duly Authorized Officer)
/s/ BLAIR L. HUNDAHL
------------------------------------
Date: April 18, 1995 Blair L. Hundahl
Vice President-Finance
(Principal Accounting Officer)
19
<PAGE>
SALICK HEALTH CARE, INC.
EXHIBIT INDEX
Exhibit Page
------- ----
27 Amended Financial Data Schedules
20
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> AUG-31-1995
<PERIOD-START> SEP-01-1994
<PERIOD-END> FEB-28-1995
<CASH> 203
<SECURITIES> 46,199
<RECEIVABLES> 43,248
<ALLOWANCES> 3,827
<INVENTORY> 1,374
<CURRENT-ASSETS> 96,888
<PP&E> 102,242
<DEPRECIATION> 29,083
<TOTAL-ASSETS> 188,783
<CURRENT-LIABILITIES> 34,669
<BONDS> 0
<COMMON> 10
0
0
<OTHER-SE> 134,004
<TOTAL-LIABILITY-AND-EQUITY> 188,783
<SALES> 0
<TOTAL-REVENUES> 73,946
<CGS> 0
<TOTAL-COSTS> 64,359
<OTHER-EXPENSES> 526
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,061
<INCOME-PRETAX> 9,771
<INCOME-TAX> 3,937
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 5,834
<EPS-PRIMARY> 0.62
<EPS-DILUTED> 0.58
</TABLE>
